NEW Zealand’s pharmaceutical
products regulator, Medsafe, has
issued a safety alert on the use of
diclofenac (Voltaren) relating to the
risk of cardiovascular events.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 15 Jul 13
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 13
